News | April 01, 2022
Evonik restructures health care business
The new structure further transitions the Health Care business line into a system solutions partner for the pharmaceutical and biotech industries
The new structure further transitions the Health Care business line into a system solutions partner for the pharmaceutical and biotech industries
Partnering to build biosynthesis processes and a pharmaceutical production platform
The net proceeds from the issue will be utilised towards the purchase of machinery, modernising existing units and expansion of its R&D facilities
The collaboration of two strong partners, CELLINK and UPM, builds confidence in making these treatments into an industrial and clinical standard, applied in a wider setting instead of remaining only within few hospitals.
Subscribe To Our Newsletter & Stay Updated
